Late valacyclovir for herpes yields greater response (Reuters)

Reuters - Therapy with valacyclovir
(Valtrex, GlaxoSmithKline), started within three months of
infection with either herpes simplex virus type 1 (HSV-1) or
HSV type 2 (HSV-2), reduces the rate of symptomatic outbreaks
compared with placebo, Seattle investigators report in the
Journal of Sexually Transmitted Diseases.



Source: http://rss.news.yahoo.com